Cellebrite Enhances Guardian with Faster, First-to-Market Evidence Review Capabilities
Go back to Cellebrite Enhances Guardian with Faster, First-to-Market Evidence Review Capabilities| (NASDAQ: CLBT) | Delayed: 11.85 -0.15 (1.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.00 | 52 Week High | $ | |||
| Open | $11.88 | 52 Week Low | $ | |||
| Day High | $11.98 | P/E | N/A | |||
| Day Low | $11.82 | EPS | $ | |||
| Volume | 933,885 | |||||
| (NASDAQ: CLBT) | Delayed: 11.85 -0.15 (1.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.00 | 52 Week High | $ | |||
| Open | $11.88 | 52 Week Low | $ | |||
| Day High | $11.98 | P/E | N/A | |||
| Day Low | $11.82 | EPS | $ | |||
| Volume | 933,885 | |||||

